26 February
2025
Pure Biologics today announced the successful completion of its Phase 0 clinical study for the novel cancer therapy, PBA-0405.
31 March
2022
Pure Biologics has published its annual report for 2021 in which it summarizes its financial results and scientific achievements.
20 December
2021
On December 18, 2021, Pure Biologics signed a contract for the lease of space for a new headquarters.
Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers